Cargando…
Urantide prevents CCl4-induced acute liver injury in rats by regulating the MAPK signalling pathway
A number of drugs and other triggers can cause acute liver injury (ALI) in clinical practice. Therefore, identifying a safe drug for the prevention of liver injury is important. The aim of the present study was to investigate the potential preventive effect and regulatory mechanism of urantide on ca...
Autores principales: | Li, Ying, Guo, Zheming, Cui, Haipeng, Wang, Tu, Xu, Yuhang, Zhao, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365596/ https://www.ncbi.nlm.nih.gov/pubmed/34328202 http://dx.doi.org/10.3892/mmr.2021.12329 |
Ejemplares similares
-
Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway
por: Cui, Haipeng, et al.
Publicado: (2021) -
The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway
por: Wang, Tu, et al.
Publicado: (2020) -
The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
por: ZHAO, JUAN, et al.
Publicado: (2013) -
Oligonol Ameliorates CCl(4)-Induced Liver Injury in Rats via the NF-Kappa B and MAPK Signaling Pathways
por: Bak, Jeonghyeon, et al.
Publicado: (2016) -
Urantide improves atherosclerosis by controlling C-reactive protein, monocyte chemotactic protein-1 and transforming growth factor-β expression in rats
por: ZHAO, JUAN, et al.
Publicado: (2014)